Through the Open COVID Pledge, industry leaders and companies are sharing their intellectual property and technologies to battle COVID-19.
A smartphone add-on, devised by an emergency medicine physician now at Stanford, detected a drunken stagger, through side-to-side sway, with 90% accuracy.
After treating a patient with an unusual ammonia metabolism problem, a Stanford researcher assembled a team to reimagine ammonia blood testing.
Stanford University bioengineers are developing a faster-acting formulation of insulin that can help diabetes patients better regulate their blood sugar levels.
A NOVA special featured Rhiju Das and the OpenVaccine project, in which gamers help scientists find an RNA molecule configuration for a COVID-19 vaccine.
Stanford researchers are devising new ways to tackle cancer through better, more sophisticated diagnostics and treatments.
Stanford psychologist Douglas Rait helps groups of Stanford Biodesign Innovation fellows hone their ability to work as a team, fueling their projects.
Researchers, working with those who are visually impaired, have developed a touch-based display that can produce physical, temporary models of objects.
A stress test helps researchers distinguish between different kinds of bacteria by testing their cell wall strength under pressure.
Zubin Damania, also known as ZDoggMD, presented at Stanford's 29th annual Jonathan J. King Lecture on the topic of connecting with patients.
The latest type 1 diabetes technology improves the stability of patients' blood sugar levels throughout the day and during sleep, according to a new trial.
At the Stanford Medicine X | CHANGE conference, patient innovators describe ways they can use their expertise to help others.
Entrepreneurs and scientists gathered at Stanford recently to discuss how to use scientific discoveries to launch startups and improve patient care.
A team of Stanford engineers has developed an approach to prosthetic creation based on performance that may allow for the design of inexpensive limbs.
Millions of people are at risk from inadequate or unreliable lighting during surgery, so a Stanford surgeon is part of a team developing an affordable surgical headlamp.
At a recent Dean's Lecture Series, Dean Lloyd Minor discussed organizational culture and diversity with Emma Walmsley, CEO of GlaxoSmithKline.